Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. 2006

Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
Department of Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan. shtakaha@east.ncc.go.jp

BACKGROUND Early recurrence is a major problem after hepatic resection of colorectal hepatic metastasis (CHM). Our aim was to investigate the relationship between time to recurrence after CHM resection and overall survival. METHODS A retrospective analysis was performed for 101 consecutive patients who underwent hepatic resection for CHM and have been followed more than 5 years. RESULTS Among 101 patients, 82 (81%) had a recurrence. Overall survival of patients with recurrence within 6 months after CHM resection was significantly worse than that of patients with recurrence after more than 6 months (P < 0.01). Overall survival was poorer when time to recurrence was shorter. One of the reasons for poor prognosis of patients with recurrence within 6 months was that only a few patients could undergo a second resection for recurrence after CHM resection. Histological type, including poorly differentiated signet ring cell or mucinous adenocarcinoma in the primary tumor, bilobar metastases, microscopic positive surgical margin and carcinoembryonic antigen (CEA) above 15 ng/ml had predictive value for decreased recurrence-free survival after CHM resection. CONCLUSIONS Short time to recurrence after CHM resection correlates with a poor prognosis. Histological type of poorly differentiated signet ring cell or mucinous adenocarcinoma in the primary tumor might be a predictor for early recurrence after CHM resection.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas

Related Publications

Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
January 2015, Journal of medicine and life,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
May 2016, Journal of gastroenterology,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
December 2006, Oncology reports,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
January 2015, Voprosy onkologii,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
March 1988, American journal of surgery,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
January 2019, Frontiers in pharmacology,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
January 2017, American journal of translational research,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
January 2020, Digestive surgery,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
February 2013, Oncology letters,
Shinichiro Takahashi, and Masaru Konishi, and Toshio Nakagohri, and Naoto Gotohda, and Norio Saito, and Taira Kinoshita
May 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!